IVIg Criteria for Use

The Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg) in Australia (the Criteria) was first published 2007 to assist clinicians and transfusion medicine professionals to identify the conditions and circumstances for which the use of intravenous immunoglobulin (IVIg) is appropriate and funded under the National Blood Agreement.

Download the Criteria

The Criteria for the clinical use of intravenous immunoglobulin in Australia Second Edition (IVIg Criteria Second Edition), released on 10 August 2012, supersedes the Criteria (2007).

The information and recommendations represent informed opinion, based where possible upon systematic review of the evidence. In the absence of published evidence, recommendations are based on clinical advice provided to the parties involved in developing the IVIg Criteria Second Edition.

Quick Reference Guide

A Quick Reference Guide and Frequently Asked Questions have been developed to accompany the IVIg Criteria Second Edition.

Order printed copies

Printed copies of the IVIg Criteria Second Edition and Quick Reference Guide can be ordered from the NBA by completing our publication online order form

Review of the Criteria

Governments recognise the need for the conditions identified in the IVIg Criteria to be reviewed regularly. The process to review the IVIg Criteria commences two years after the release of each new edition. A review process can take two to three years to complete. Details of the 2010-2011 review can be found at Appendix D of the IVIg Criteria Second Edition.

Related resources

Summary of Key Changes to Second Edition 

Patient Factsheets

For more information

  • Email ivigcriteria [at] blood [dot] gov [dot] au (subject: IVIg%20Criteria%20Enquiry)